Acrisure Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Acrisure Capital Management's JNJ Position: Q2 2023 in Review
Acrisure Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 5,515 shares — an estimated $855K sold.
Acrisure Capital Management first reported a position in JNJ in Q4 2022 and held it in 2 quarters. The position peaked at $1.33M in Q4 2022. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.
- Acrisure Capital Management reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
- Acrisure Capital Management sold 5,515 Johnson & Johnson shares in Q2 2023, an estimated $855K.
- Acrisure Capital Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 2 quarters.
- Acrisure Capital Management's Johnson & Johnson position peaked at $1.33M in Q4 2022.
- 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.
Based on Acrisure Capital Management's 13F filing for Q2 2023.